NEW YORK—J.P. Morgan initiated coverage of Salesforce (NYSE: CRM) at Overweight on Thursday, assigning a December 2027 price target of $250 and moving the stock out of Not Rated status. Analyst Samik Chatterjee argued that Wall Street has mispriced the stock by treating competitive threats from frontier AI models and broader enterprise software disruption as existential risks rather than contained ones.
Chatterjee's core argument is that the selloff has gone too far. Salesforce shares are down 27 percent year to date, and he said the current price embeds an assumption of continued growth deceleration that the fundamentals do not support. His $250 target implies roughly 29 percent upside from Wednesday's close, based on an expected re-rating tied directly to when revenue growth picks back up.
The bull case hinges on an acceleration in Salesforce's core business in the second half of fiscal year 2027—the period ending January 2027. Chatterjee said fears about AI disruption apply to only a limited portion of Salesforce's business, not the broader platform, and competitive pressure from newer models should not derail the company's trajectory. He said the market is pricing in a scenario that overstates the threat.
Chatterjee pointed to three specific growth drivers he wants investors to track: Agentforce, the company's autonomous agent platform; Data 360; and Headless 360. He described Agentforce as central to Salesforce's position as enterprise software moves toward AI-driven automation. Data 360 and Headless 360 represent additional product bets he expects to contribute meaningfully in coming quarters, though neither has yet moved the needle enough to show in the top line.
The Rule of 50 sits at the center of the valuation argument. The metric combines a company's revenue growth rate and its operating profit margin; a combined reading of 50 or higher is considered healthy for a software business and is a benchmark Salesforce has publicly pursued. Chatterjee said the market is not giving Salesforce credit for a realistic path back to that threshold, and a return to it would justify a significant multiple expansion.
The next concrete test comes Aug. 26, when Salesforce reports fiscal second-quarter results. J.P. Morgan set its revenue estimate for that quarter at $11.31 billion, roughly $50 million—about 0.4 percent—below the current Wall Street consensus. Chatterjee said he expects second-quarter results to offer early evidence that the core business recovery is underway. Given how tightly that estimate sits relative to consensus, even a modest revenue beat or a raise to full-year guidance is enough to shift near-term sentiment.
J.P. Morgan was not alone in updating its view. UBS raised its price target on CRM to $210 from $185 while holding its Neutral rating—higher conviction without a change in direction. Wells Fargo lifted its target to $205 from $200. Stifel reiterated a Buy rating with a $250 price target, putting it in exact alignment with J.P. Morgan's number. The clustering of $250 targets from two independent firms narrows the range of outcomes the Street is debating at the top end.
Both UBS and Wells Fargo stopped short of an Overweight call, keeping their targets 16 to 20 percent below J.P. Morgan's. That gap reflects genuine disagreement about how quickly the core business can reaccelerate and whether Agentforce adoption will prove fast enough to matter in the fiscal 2027 time frame Chatterjee is underwriting.
Salesforce shares rose 1.90 percent intraday following the J.P. Morgan initiation. The move was meaningful but left the stock well below the levels needed to close its year-to-date gap. At 27 percent down for 2026, CRM is among the weaker performers in large-cap enterprise software, and Chatterjee framed that weakness explicitly as the opportunity rather than a warning sign.
The Aug. 26 earnings report will either validate or pressure the J.P. Morgan thesis on a short time horizon. If Salesforce delivers revenue at or above the $11.31 billion estimate and raises full-year targets, the re-rating argument gains traction quickly. If results disappoint or guidance stays flat, the 27 percent drawdown deepens and the Rule of 50 path becomes harder to defend.
